A clinical study of the V540C vaccine in healthy adults (V540C-003)
V540C-003
Phase 1 other active
Quick answer
A clinical study of the V540C vaccine in healthy adults (V540C-003) for Human Papilloma virus is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Human Papilloma virus
- Phase
- Phase 1
- Modality
- other
- Status
- active